Selinexor with dexamethasone for treating relapsed and refractory multiple myeloma after 4 or more treatments
Technology appraisal guidance
Reference number: TA970
Published:
Please note the update to the committee meeting date. The committee meeting is now scheduled to take place on Wednesday 10 January 2024. This change is to ensure there is enough time to discuss the topic in full during the meeting.